Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of LC-Z300-01 in Adults With Type 2 Diabetes
NCT06847178Phase 3Not yet recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Mar 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of LC-Z300-01 in type 2 diabetes mellitus (T2DM), sponsored by Shanghai Changzheng Hospital. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
LC-Z300-01
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06847178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06847178.